BiPAP ventilation as assistance for patients presenting with respiratory distress in the department of emergency medicine.

Chaim Yosefy, Emile Hay, Asaf Ben-Barak, Hashmonai Derazon, Eli Magen, Leonardo Reisin, Shimon Scharf
{"title":"BiPAP ventilation as assistance for patients presenting with respiratory distress in the department of emergency medicine.","authors":"Chaim Yosefy,&nbsp;Emile Hay,&nbsp;Asaf Ben-Barak,&nbsp;Hashmonai Derazon,&nbsp;Eli Magen,&nbsp;Leonardo Reisin,&nbsp;Shimon Scharf","doi":"10.1007/BF03256662","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Noninvasive ventilatory support (NIVS) is intended to provide ventilatory assistance for a wide range of respiratory disturbances. The use of NIVS for treatment of respiratory distress may be applicable in the emergency department (ED). It may prevent endotracheal intubation and, likewise, may favorably influence the course of the patient's hospitalization, depending on the primary disease or ventilatory disturbance.</p><p><strong>Objective: </strong>To evaluate the efficacy of bilevel positive airway pressure (BiPAP) ventilation in patients with acute respiratory distress presenting in the ED.</p><p><strong>Methods: </strong>A prospective, uncontrolled, nonrandomized, nonblind study enrolled 30 patients. They were cooperative and hemodynamically stable, aged over 18 years, and presented with acute respiratory distress as defined by predetermined criteria. They were connected to a BiPAP machine through a face mask, using an initial pressure of 8/3 cm H(2)O, which was gradually raised to 12/7 cm H(2)O inspiratory positive airway pressure/expiratory positive airway pressure. Standard drugs, inhalation and oxygen therapies were administered as needed. The BiPAP was disconnected either upon relief of respiratory distress or on deterioration of the patient's condition.</p><p><strong>Results: </strong>Of the 30 patients in the study, 19 had cardiogenic pulmonary edema, four had acute asthma, three had exacerbation of COPD, three had pneumonia and one had malignant pleural effusion. BiPAP was instituted subsequent to failure of standard therapies. Twenty-six patients were classified as responders to the BiPAP ventilation and four as nonresponders (three patients were intubated after 1 hour and one patient 24 hours, post BiPAP). The total length of stay (LOS) in the ED was 3-5 hours and the mean LOS in hospital was 4.1 +/- 1.5 days, versus 6.5 +/- 1.2 days in LOS reports of similar patients in the same hospital during 1999, who did not undergo BiPAP ventilation. No other complications were observed.</p><p><strong>Conclusions: </strong>We found BiPAP ventilation simple, safe, effective and well tolerated by patients in respiratory distress. The rate of endotracheal intubation after successful BiPAP ventilation was low. In carefully selected patients with respiratory distress, BiPAP ventilation may successfully replace endotracheal intubation.</p>","PeriodicalId":86933,"journal":{"name":"American journal of respiratory medicine : drugs, devices, and other interventions","volume":"2 4","pages":"343-7"},"PeriodicalIF":0.0000,"publicationDate":"2003-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF03256662","citationCount":"17","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of respiratory medicine : drugs, devices, and other interventions","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/BF03256662","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 17

Abstract

Background: Noninvasive ventilatory support (NIVS) is intended to provide ventilatory assistance for a wide range of respiratory disturbances. The use of NIVS for treatment of respiratory distress may be applicable in the emergency department (ED). It may prevent endotracheal intubation and, likewise, may favorably influence the course of the patient's hospitalization, depending on the primary disease or ventilatory disturbance.

Objective: To evaluate the efficacy of bilevel positive airway pressure (BiPAP) ventilation in patients with acute respiratory distress presenting in the ED.

Methods: A prospective, uncontrolled, nonrandomized, nonblind study enrolled 30 patients. They were cooperative and hemodynamically stable, aged over 18 years, and presented with acute respiratory distress as defined by predetermined criteria. They were connected to a BiPAP machine through a face mask, using an initial pressure of 8/3 cm H(2)O, which was gradually raised to 12/7 cm H(2)O inspiratory positive airway pressure/expiratory positive airway pressure. Standard drugs, inhalation and oxygen therapies were administered as needed. The BiPAP was disconnected either upon relief of respiratory distress or on deterioration of the patient's condition.

Results: Of the 30 patients in the study, 19 had cardiogenic pulmonary edema, four had acute asthma, three had exacerbation of COPD, three had pneumonia and one had malignant pleural effusion. BiPAP was instituted subsequent to failure of standard therapies. Twenty-six patients were classified as responders to the BiPAP ventilation and four as nonresponders (three patients were intubated after 1 hour and one patient 24 hours, post BiPAP). The total length of stay (LOS) in the ED was 3-5 hours and the mean LOS in hospital was 4.1 +/- 1.5 days, versus 6.5 +/- 1.2 days in LOS reports of similar patients in the same hospital during 1999, who did not undergo BiPAP ventilation. No other complications were observed.

Conclusions: We found BiPAP ventilation simple, safe, effective and well tolerated by patients in respiratory distress. The rate of endotracheal intubation after successful BiPAP ventilation was low. In carefully selected patients with respiratory distress, BiPAP ventilation may successfully replace endotracheal intubation.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
BiPAP通气对急诊科呼吸窘迫患者的帮助
背景:无创通气支持(NIVS)旨在为各种呼吸障碍提供通气辅助。使用NIVS治疗呼吸窘迫可能适用于急诊科(ED)。它可以防止气管内插管,同样,根据原发疾病或呼吸障碍,它可以有利地影响患者的住院过程。目的:评价双水平气道正压通气(BiPAP)对急诊科急性呼吸窘迫患者的疗效。方法:一项前瞻性、非随机、非盲研究,纳入30例患者。他们都很配合,血流动力学稳定,年龄在18岁以上,表现出预先确定的急性呼吸窘迫标准。患者通过面罩连接BiPAP机器,初始压力为8/ 3cm H(2)O,逐渐升高至12/ 7cm H(2)O吸气气道正压/呼气气道正压。根据需要给予标准药物、吸入和氧气治疗。在呼吸窘迫缓解或患者病情恶化时断开BiPAP。结果:30例患者中心源性肺水肿19例,急性哮喘4例,COPD加重3例,肺炎3例,恶性胸腔积液1例。BiPAP是在标准治疗失败后建立的。26例患者对BiPAP通气有反应,4例无反应(3例患者在BiPAP通气后1小时插管,1例患者24小时插管)。在急诊室的总住院时间(LOS)为3-5小时,平均住院时间(LOS)为4.1 +/- 1.5天,而1999年同一家医院未接受BiPAP通气的类似患者的住院时间报告为6.5 +/- 1.2天。无其他并发症。结论:BiPAP通气简单、安全、有效,对呼吸窘迫患者耐受性好。BiPAP通气成功后气管插管率低。在精心挑选的呼吸窘迫患者中,BiPAP通气可以成功地取代气管插管。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The emerging role of leukotriene modifiers in allergic rhinitis. Is there a role for systemic corticosteroids in the management of stable chronic obstructive pulmonary disease? Pseudomonal infections in patients with COPD: epidemiology and management. Treatment of community-acquired lower respiratory tract infections during pregnancy. Anti-interleukin-5 monoclonal antibodies: preclinical and clinical evidence in asthma models.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1